Skip to main content
News article30 June 2021BrusselsDirectorate-General for Trade1 min read

EU extends COVID-19 vaccines export transparency and authorisation mechanism

The EU has today extended until 30 September 2021 the COVID-19 vaccines export transparency and authorisation mechanism in its current form.

The purpose of the mechanism is to secure deliveries of vaccines to Europeans in line with companies’ contractual obligations. The system currently in place has significantly improved the transparency of vaccines production, deliveries and supply chains. It has also shown that the EU is a global leader in terms of vaccines exports. The EU remains fully committed to the principles of international solidarity and international responsibility. Vulnerable, low- and middle-income countries will continue to be exempted from the scope of the mechanism.

For more information

Commission Implementing Regulation (EU) 2021/1071 of 29 June 2021

Frequently asked questions


Publication date
30 June 2021
Directorate-General for Trade
Trade topics
  • Actions against exports from the EU